Canada Diabetes Care Drugs And Devices Market Share

Statistics for the 2023 & 2024 Canada Diabetes Care Drugs And Devices market share, created by Mordor Intelligence™ Industry Reports. Canada Diabetes Care Drugs And Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Canada Diabetes Care Drugs And Devices Industry

Manufacturers have driven constant innovations to compete in the market. The major players, such as Abbott and Medtronic, have undergone many mergers, acquisitions, and partnerships to establish market dominance while also adhering to organic growth strategies, which is evident from the R&D spending of these companies. The manufacturers of insulin delivery devices are spending a massive amount on the R&D of the devices. For example, Novo Nordisk partnered with Abbott Diabetes Care, which may help to enable insulin data to be shared between Novo Nordisk-connected insulin pens and digital health tools compatible with the FreeStyle Libre portfolio of products. Mega Blockbuster Lantus, manufactured by Sanofi, led the basal insulin field.

Canada Diabetes Care Drugs & Devices Market Leaders

  1. Roche

  2. Medtrionic

  3. Sanofi

  4. Novo Nordisk

  5. Omnipod

*Disclaimer: Major Players sorted in no particular order

Canada Diabetes Care Drugs And Devices Market Concentration

Canada Diabetes Care Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)